Belgium - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Belgium Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes was up 4.4% year on year. In 2019, the country was number 5 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes at €429.86 Per Capita. Belgium is overtaken by Ireland, which was number 4 with €447.21 Per Capita and is followed by France at €419.57 Per Capita. Switzerland topped the ranking with €666.37 Per Capita in 2019, a growth of 3.2% versus 2018. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.

Loading...

Date Euros Per Capita
2019 429.86
2018 427.66
2017 401.47
2016 383.92
2015 374.12
Download all data from 2003 to 2019

How does Belgium rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
4 #4
Ireland
447.21 2019 -0.8 % +2.1 % View data
5 #5
Belgium
429.86 2019 +0.5 % +4.4 % View data
6 #6
France
419.57 2019 +0.6 % +1.9 % View data
Compare all 33 countries

Go Top